Distribution of intramyocardially injected extracellular MR contrast medium: effects of concentration and volume.
The purpose of this study was to assess the potential of intramyocardially injected Gd-DTPA solution as a marker for distribution of intramyocardially delivered therapeutic solutions. The effects of concentration and volume of the extracellular MR contrast medium Gd-DTPA on signal intensity and spatial extent of enhancement was determined after intramyocardial delivery. In anesthetized pigs (n=11), mixtures of Gd-DTPA (0.15, 0.1 and 0.05 mmol/ml) and Evan's blue tissue dye (3%) were injected into the wall of the left ventricle. In each pig 1 ml of 0.15 mmol/ml, 2 ml of 0.1 ml and 3 ml of 0.05 mmol/ml Gd-DTPA were injected remote from each other. Arterial blood pressure, heart rate and ECG were monitored throughout the procedure. Five minutes after injections were performed, the pigs were killed and the hearts excised. T1-weighted spin-echo MR images were acquired to measure regional signal intensity (SI) and extent of the enhanced regions. The hearts were sliced and mass of blue stained regions was determined and compared with mass of enhanced areas on MRI. Gd-DTPA significantly (p<0.001) increased regional SI compared with remote myocardium in a concentration dependent fashion (109 +/- 4% at 0.05 mmol/ml, 202 +/- 7% at 0.1, and 327 +/- 6% at 0.15) while the mass of enhanced region was 0.6 +/- 0.1 g after injection of 1 ml, 1.4 +/- 0.2 g after 2 ml and 2.3 +/- 0.3 g after 3 ml (p<0.001). Regression and Bland-Altman analysis revealed that there was close correlation and agreement between MRI and histomorphometry (r=0.98, p<0.001). Magnitude and spatial extent of enhancement depend on concentration and volume of injected contrast medium. Intramyocardial injection of extracellular MR contrast media may be useful as a marker for the extent of distribution of intramyocardially delivered therapeutic solutions.
Krombach
Gabriele A
GA
Department of Radiology, University of California San Francisco, 505 Parnassus Avenue, L308, San Francisco, CA 94143-0628, USA.
Baireuther
Ronald
R
Higgins
Charles B
CB
Saeed
Maythem
M
D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005070:Evans Blue / Q000493:pharmacokinetics; D005110:Extracellular Space / Q000378:metabolism; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007089:Image Enhancement; D007273:Injections, Intramuscular; D008279:Magnetic Resonance Imaging; D008297:Male; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology; D014018:Tissue Distribution
D003287:Contrast Media; D005070:Evans Blue; D019786:Gadolinium DTPA